- call +1-201-465-4211
- email sales@mrinsights.biz
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
Scope of the Report:
The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.
Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.
North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is not intense. Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Perphenazine is expected to grow at a CAGR of roughly 0.7% over the next five years, will reach 100 million US$ in 2024, from 95 million US$ in 2019, according to a new study.
This report focuses on the Perphenazine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Forms
Injectable Solution
Market Segment by Applications, can be divided into
Psychosis
Antiemetic
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perphenazine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Perphenazine, with price, sales, revenue and global market share of Perphenazine in 2017 and 2018.
Chapter 3, the Perphenazine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perphenazine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Perphenazine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Perphenazine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Perphenazine Introduction
1.2 Market Analysis by Type
1.2.1 Oral Forms
1.2.2 Injectable Solution
1.3 Market Analysis by Applications
1.3.1 Psychosis
1.3.2 Antiemetic
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Perphenazine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Perphenazine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sandoz
2.2.1 Business Overview
2.2.2 Perphenazine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sandoz Perphenazine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Endo
2.3.1 Business Overview
2.3.2 Perphenazine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Endo Perphenazine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Perphenazine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Perphenazine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 ZHPHARMA
2.5.1 Business Overview
2.5.2 Perphenazine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ZHPHARMA Perphenazine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Shandong Boshan Pharma
2.6.1 Business Overview
2.6.2 Perphenazine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shandong Boshan Pharma Perphenazine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Perphenazine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Perphenazine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Perphenazine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Perphenazine Manufacturer Market Share in 2018
3.3.2 Top 6 Perphenazine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Perphenazine Market Analysis by Regions
4.1 Global Perphenazine Sales, Revenue and Market Share by Regions
4.1.1 Global Perphenazine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Perphenazine Revenue and Market Share by Regions (2014-2019)
4.2 North America Perphenazine Sales and Growth Rate (2014-2019)
4.3 Europe Perphenazine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Perphenazine Sales and Growth Rate (2014-2019)
4.5 South America Perphenazine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Perphenazine Sales and Growth Rate (2014-2019)
5 North America Perphenazine by Country
5.1 North America Perphenazine Sales, Revenue and Market Share by Country
5.1.1 North America Perphenazine Sales and Market Share by Country (2014-2019)
5.1.2 North America Perphenazine Revenue and Market Share by Country (2014-2019)
5.2 United States Perphenazine Sales and Growth Rate (2014-2019)
5.3 Canada Perphenazine Sales and Growth Rate (2014-2019)
5.4 Mexico Perphenazine Sales and Growth Rate (2014-2019)
6 Europe Perphenazine by Country
6.1 Europe Perphenazine Sales, Revenue and Market Share by Country
6.1.1 Europe Perphenazine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Perphenazine Revenue and Market Share by Country (2014-2019)
6.2 Germany Perphenazine Sales and Growth Rate (2014-2019)
6.3 UK Perphenazine Sales and Growth Rate (2014-2019)
6.4 France Perphenazine Sales and Growth Rate (2014-2019)
6.5 Russia Perphenazine Sales and Growth Rate (2014-2019)
6.6 Italy Perphenazine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Perphenazine by Country
7.1 Asia-Pacific Perphenazine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Perphenazine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Perphenazine Revenue and Market Share by Country (2014-2019)
7.2 China Perphenazine Sales and Growth Rate (2014-2019)
7.3 Japan Perphenazine Sales and Growth Rate (2014-2019)
7.4 Korea Perphenazine Sales and Growth Rate (2014-2019)
7.5 India Perphenazine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Perphenazine Sales and Growth Rate (2014-2019)
8 South America Perphenazine by Country
8.1 South America Perphenazine Sales, Revenue and Market Share by Country
8.1.1 South America Perphenazine Sales and Market Share by Country (2014-2019)
8.1.2 South America Perphenazine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Perphenazine Sales and Growth Rate (2014-2019)
8.3 Argentina Perphenazine Sales and Growth Rate (2014-2019)
8.4 Colombia Perphenazine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Perphenazine by Countries
9.1 Middle East and Africa Perphenazine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Perphenazine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Perphenazine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Perphenazine Sales and Growth Rate (2014-2019)
9.3 Turkey Perphenazine Sales and Growth Rate (2014-2019)
9.4 Egypt Perphenazine Sales and Growth Rate (2014-2019)
9.5 Nigeria Perphenazine Sales and Growth Rate (2014-2019)
9.6 South Africa Perphenazine Sales and Growth Rate (2014-2019)
10 Global Perphenazine Market Segment by Type
10.1 Global Perphenazine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Perphenazine Sales and Market Share by Type (2014-2019)
10.1.2 Global Perphenazine Revenue and Market Share by Type (2014-2019)
10.2 Oral Forms Sales Growth and Price
10.2.1 Global Oral Forms Sales Growth (2014-2019)
10.2.2 Global Oral Forms Price (2014-2019)
10.3 Injectable Solution Sales Growth and Price
10.3.1 Global Injectable Solution Sales Growth (2014-2019)
10.3.2 Global Injectable Solution Price (2014-2019)
11 Global Perphenazine Market Segment by Application
11.1 Global Perphenazine Sales Market Share by Application (2014-2019)
11.2 Psychosis Sales Growth (2014-2019)
11.3 Antiemetic Sales Growth (2014-2019)
12 Perphenazine Market Forecast (2019-2024)
12.1 Global Perphenazine Sales, Revenue and Growth Rate (2019-2024)
12.2 Perphenazine Market Forecast by Regions (2019-2024)
12.2.1 North America Perphenazine Market Forecast (2019-2024)
12.2.2 Europe Perphenazine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Perphenazine Market Forecast (2019-2024)
12.2.4 South America Perphenazine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Perphenazine Market Forecast (2019-2024)
12.3 Perphenazine Market Forecast by Type (2019-2024)
12.3.1 Global Perphenazine Sales Forecast by Type (2019-2024)
12.3.2 Global Perphenazine Market Share Forecast by Type (2019-2024)
12.4 Perphenazine Market Forecast by Application (2019-2024)
12.4.1 Global Perphenazine Sales Forecast by Application (2019-2024)
12.4.2 Global Perphenazine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Perphenazine Picture
Table Product Specifications of Perphenazine
Figure Global Sales Market Share of Perphenazine by Types in 2018
Table Perphenazine T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
